Akihiko Yoshizawa

Somatic mutations affect key pathways in lung adenocarcinoma

Li Ding, Gad Getz, David A. Wheeler et al. · Nature · 2008 · 2.7K citations · Full text

Medicine, Genetics, Oncology +16

Characterizing the cancer genome in lung adenocarcinoma

Barbara A. Weir, Michele Sue‐Ann Woo, Gad Getz et al. · Nature · 2007 · 1.1K citations · Full text

Medicine, Genetics, Oncology +17

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

Akihiko Yoshizawa, Noriko Motoi, Gregory J. Riely et al. · Modern Pathology · 2011 · 994 citations · Full text

Medicine, Oncology, Pathology +15

Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients

Akihiko Yoshizawa, Shinji Sumiyoshi, Makoto Sonobe et al. · Journal of Thoracic Oncology · 2012 · 446 citations · Full text

Medicine, Genetics, Oncology +16

A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors

Gabriel Sica, Akihiko Yoshizawa, Camelia S. Sima et al. · The American Journal of Surgical Pathology · 2010 · 330 citations

Medicine, Oncology, Pathology +17